MOTS-c

Buy MOTS-c Online

Book Now

Questions about peptides? Click here to schedule a free consultation with a physician.

x
Secure Encrypted Payments

Buy MOTS-c online and compare current listed pricing, available peptide presentations, order details, and safety basics before you continue. You can review the selected form, quantity, access information, and handling notes together so the product you choose matches your plan. For customers exploring US delivery from Canada, checkout details should match the listing and any guidance from a licensed clinician.

MOTS-c Price and Available Options

Start with the current listed pricing shown for the selected option, then compare what that selection actually contains. The MOTS-c price may reflect form, quantity, concentration, total contents, packaging, and any handling needs shown on the product listing. A lower visible line item is not always the better match if it represents a different presentation or a smaller total amount.

MOTS-c peptide price comparisons are most useful when you look beyond the first number. Check whether the listing is for a single unit, a multi-unit pack, a vial, tablets, powder, or another presentation if those options are displayed. Customers paying cash can compare MOTS-c cost without insurance against the selected quantity and any checkout charges that apply.

What to compareWhere to lookWhy it matters
Selected presentationProduct option or variantDifferent forms should not be treated as interchangeable.
Total contentsStrength, concentration, or pack detailTotal amount may differ from a single use or intended supply.
Quantity selectedQuantity field or cartThe final total can change when more units are added.
Handling notesProduct or checkout detailsPeptide products may need extra care during storage.

Quick tip: Match the exact product form before comparing totals across listings.

If a listing shows separate options, open each selection before deciding. Price, available quantity, and handling details can change when the selected presentation changes. If the product page does not display a strength or form you expected, do not assume another option is equivalent.

How to Buy MOTS-c Online

When you buy MOTS-c online, begin by selecting the presentation that matches the product details you are trying to fill. Review the listing name, quantity, and any product notes before checkout. If extra order information is requested, provide accurate details so the selected product can be assessed correctly.

BorderFreeHealth supports cash-pay, cross-border access where permitted. Because access rules can differ by product and location, complete checkout with the same name, contact details, and product selection you want associated with the order. This helps prevent delays caused by mismatched form, quantity, or destination information.

  • Choose the form: Confirm the listed presentation before adding it.
  • Review the quantity: Check how many units the cart contains.
  • Confirm details: Make sure contact and destination information are accurate.
  • Check handling notes: Follow any storage or delivery instructions provided.
  • Keep records: Save product and checkout details for your clinician.

For orders involving US shipping from Canada, review the destination and delivery options displayed during checkout. Do not rely on old screenshots, prior listings, or third-party descriptions when checking what is available today. The current product page and cart are the best places to confirm the selected option.

Product Details to Match Before Checkout

MOTS-c can appear in peptide discussions in several forms, and the product page should guide the buying decision by what is actually listed. If a MOTS-c injection, MOTS-c tablets, powder, vial, or other form is shown, compare the exact presentation rather than relying on the product name alone. The route and preparation details can affect handling, storage, and how a clinician may want the product documented.

Product images can be helpful, but they should not replace the written listing details. Read the option name, variant selector, and cart summary together. If the form, concentration, or unit count is unclear, pause before checkout and clarify the selection rather than substituting another peptide product.

  • Form: Injection, tablet, powder, or vial if listed.
  • Strength: Any mg or concentration detail shown.
  • Total amount: Contents across the whole package.
  • Supplies: Any needed items noted separately.
  • Storage: Temperature and handling instructions.
  • Expiry: Use-by information when supplied.

Why it matters: Peptide products with similar names can require different handling and monitoring.

A practical comparison starts with the selection you can actually place in the cart. If two listings use different units, ask whether you are comparing total peptide content, concentration, delivered volume, or package count. Those details matter more than the product name repeated in search results.

What This Peptide Is Used For

MOTS-c peptide is a mitochondrial-derived peptide, meaning a small protein-like messenger associated with mitochondria, the energy-producing parts of cells. Research has explored its relationship to metabolic signaling, skeletal muscle activity, glucose handling, and aging-related pathways. Much of the discussion around this peptide comes from laboratory, animal, or early human research rather than a standard product label.

Interest in MOTS-c metabolism, energy, and insulin sensitivity claims usually comes from studies examining how cells respond to exercise-like stress and nutrient signals. These research themes do not guarantee individual results. They also do not replace a clinician’s assessment of weight, glucose, cardiovascular risk, medications, or existing conditions.

People searching for MOTS-c for weight loss should be especially cautious with expectations. Weight management is influenced by diet, activity, sleep, medications, hormones, medical history, and long-term support. Patients comparing medically supervised options can browse Obesity Products or Type 2 Diabetes Products when those categories match their broader care discussion.

If your main goal is metabolic health, focus on what the product listing can confirm: form, quantity, handling needs, and access details. Clinical goals, outcome expectations, and whether this peptide fits your situation should be discussed with a qualified professional who knows your health history.

Form, Strength, and Dosage Details

The product listing can help you match form and quantity, but it should not set your individual MOTS-c dosage. A MOTS-c dosage per day, weekly schedule, or cycling plan should come from a clinician’s instructions when use is being considered. Do not adjust a plan based on online comments, fitness forums, or another person’s peptide routine.

When reviewing a product option, look for the units used in the listing. Some peptide listings may describe total mg, concentration, vial contents, tablets per pack, or supplied quantity. Those terms are not the same. Total contents describe the amount in the package, while an individual plan may involve a different measured amount.

  • mg: Often reflects total peptide amount.
  • mL: Describes liquid volume, not potency by itself.
  • Concentration: Shows amount per volume when provided.
  • Pack count: Shows how many units are included.
  • Directions: Follow clinician or label instructions when supplied.

If you are comparing MOTS-c peptide cost across forms, do not divide totals unless the units match. A vial, tablet pack, and prepared injection may use different measures. The safest product decision is to match the exact presentation first, then compare total cost for that same type of item.

Customers sometimes search for dose information before they know which form is listed. That can lead to confusion. First confirm the available presentation on the product page, then discuss any dosing question with a clinician who can account for your age, other medications, metabolic health, and monitoring needs.

Storage, Handling, and Travel Basics

Peptide products can be sensitive to heat, light, moisture, and handling, although the exact instructions depend on the supplied form. Follow the product label, packaging, and any information provided with the order. If storage details are not clear, avoid guessing based on another peptide or an online discussion.

Before checkout, consider whether the selected option needs refrigeration, protection from freezing, or careful handling after opening. If a product is supplied as a powder, prepared liquid, tablet, or vial, the storage instructions may differ. Handling matters because poor storage can affect product quality even when the item name is correct.

  • Check temperature: Follow the storage range provided.
  • Protect packaging: Keep seals intact until use.
  • Inspect contents: Do not use damaged or contaminated products.
  • Plan travel: Keep labels and storage needs in mind.
  • Avoid mixing: Use only supplied or instructed materials.

Travel planning is especially important if the product must stay within a temperature range. Keep the product in its original packaging when possible, and avoid leaving it in hot vehicles, checked luggage, or direct sunlight. If a shipment or package appears compromised, document the issue and seek guidance before using the product.

Handling details are part of the buying decision, not an afterthought. A product that fits your budget may still be the wrong choice if you cannot store it as directed. Review storage expectations before checkout so you can plan responsibly.

Safety, Side Effects, and Monitoring

MOTS-c side effects are not as well characterized as those of many long-approved medicines with detailed product labeling. Reported or plausible reactions may include injection-site discomfort when injectable forms are used, headache, nausea, fatigue, flushing, rash, or digestive upset. Because research is still developing, new safety information may emerge over time.

Seek urgent medical help for symptoms of a serious allergic reaction, such as swelling of the face or throat, trouble breathing, widespread hives, fainting, or chest tightness. Stop using any product that looks contaminated, has a broken seal, or was not stored as directed. Keep the packaging available if a clinician needs to identify what was used.

Interactions and health conditions

Because MOTS-c is discussed in relation to insulin sensitivity and glucose handling, people using insulin, sulfonylureas, GLP-1 medicines, or other glucose-lowering treatments should raise the topic with a clinician before considering use. Monitoring may be more important for patients with diabetes, kidney disease, liver disease, cardiovascular conditions, active cancer, pregnancy, breastfeeding, or a history of severe allergies.

Athletes subject to drug testing should also be careful. Some peptide products may create anti-doping concerns depending on the sport, organization, and intended use. Do not assume that a product sold online is permitted in competition or safe for every training program.

  • Allergy history: Discuss prior peptide or injectable reactions.
  • Glucose treatment: Ask about monitoring if using diabetes medicines.
  • Pregnancy status: Raise pregnancy or breastfeeding before use.
  • Competition rules: Check anti-doping requirements independently.
  • New symptoms: Report unexpected reactions promptly.

Why it matters: A safe order starts with matching the product to your health situation.

Compare Peptide and Metabolic Options

If your clinician has discussed peptide therapy, compare products by intended use, form, monitoring needs, and handling requirements. The Peptides Collection can help you browse related listings without mixing up products that have different roles. Do not treat products in the same category as substitutes unless a qualified professional has specifically made that recommendation.

Separate peptide listings such as Tesamorelin and Ipamorelin may have different selection details, safety considerations, and clinical discussions. Compare their listed forms and handling requirements rather than assuming they work the same way. Product names that appear together in search results can still represent very different options.

For patients researching the weight-management side of peptide therapy, Peptides For Weight Loss can support a broader conversation about expectations and safety. Use that type of resource to prepare questions, not to replace individualized care. The PDP remains the place to check the current listing, quantity, and product-specific details.

Authoritative Sources

For scientific context, a peer-reviewed review on mitochondrial peptides describes MOTS-c research in metabolism and aging-related pathways. It is useful background, but it does not confirm that a specific product is appropriate for a specific person.

A USADA athlete safety resource discusses peptide-related anti-doping concerns and the risks of relying on unverified supplement or peptide claims. Athletes should check their own governing body rules before use.

This content is for informational purposes only and is not a substitute for professional medical advice.

Research & Education Tool

MOTS-c Dosage Calculator

Enter the vial amount, diluent volume, syringe size, and target amount to estimate concentration, draw volume, and approximate vial yield.

For research and educational use only. Check all values against the product label, certificate of analysis, and any applicable professional guidance before relying on the result.

mg

Concentration - mcg / mL
Volume per Dose - -
Estimated Draws / Vial - rounded down to whole draws

Click here to order.

Draw Reference

Enter values to estimate the syringe mark.

0 - - - -

Express Shipping - from $25.00

Shipping with this method takes 3-5 days

Prices:
  • Dry-Packed Products $25.00
  • Cold-Packed Products $35.00
Shipping Countries:
  • United States (all contiguous states**)
  • Worldwide (excludes some countries***)

Standard Shipping - $15.00

Shipping with this method takes 5-10 days

Prices:
  • Dry-Packed Products $15.00
  • Not available for Cold-Packed products
Shipping Countries:
  • United States (all contiguous states**)
  • Worldwide (excludes some countries***)

Rewards Program

Earn points on birthdays, product orders, reviews, friend referrals, and more! Enjoy your medication at unparalleled discounts while reaping rewards for every step you take with us.

You can read more about rewards here.

POINT VALUE

100 points
1 USD

How to earn points

  • 1Register and/or Login
    Create an account and start earning.
  • 2Earn Rewards
    Earn points every time you shop or perform certain actions.
  • 3Redeem
    Redeem points for exclusive discounts.

You Might Also Like

GHK-Cu

$47.49

  • In Stock
  • Express Shipping
Our Price $47.49
Select options This product has multiple variants. The options may be chosen on the product page
Epithalon

$47.49

  • In Stock
  • Express Shipping
Our Price $47.49
Select options This product has multiple variants. The options may be chosen on the product page
Tesamorelin

$75.99

  • In Stock
  • Express Shipping
US $6,040.69
Our Price $75.99
Select options This product has multiple variants. The options may be chosen on the product page
Retatrutide

$85.49

  • In Stock
  • Express Shipping
Our Price $85.49
Select options This product has multiple variants. The options may be chosen on the product page

Peptide Screening Form

Patient Information

Please provide your basic demographic information.

Type your date of birth in MM/DD/YYYY format.

Peptides of Interest

Peptides of Interest

Select the peptides you are interested in or have been recommended.

Medical History & Screening

Medical History & Screening

Please indicate if any of the following apply to you. Red flag alerts will appear if a condition contraindicates any of the available peptide therapies.

Contraindicated for CJC-1295: Growth hormone-releasing peptides like CJC-1295 are contraindicated in patients with active cancer because they may promote cell proliferation and tumor growth.

Contraindicated for Ipamorelin: Ipamorelin stimulates growth hormone release, which may promote tumor growth and cell proliferation in active cancers.

Contraindicated for Sermorelin: Sermorelin increases growth hormone production, which may stimulate growth of existing tumors.

Contraindicated for BPC-157: BPC-157 promotes angiogenesis (new blood vessel formation), which could support tumor growth and metastasis in active cancers.

Contraindicated for AOD-9604: Although AOD-9604 is a modified GH fragment, it may still interact with growth-related pathways in patients with active malignancies.

Contraindicated for TB-500 (Thymosin Beta-4): TB-500 promotes cell migration and angiogenesis, which may facilitate tumor growth and metastasis in active cancers.

Contraindicated for GHK-Cu: GHK-Cu promotes angiogenesis and tissue remodeling, which may support tumor growth in patients with active cancer.

Contraindicated for Epithalon (Epitalon): Epithalon stimulates telomerase activity. Cancer cells exploit telomerase to achieve immortality, potentially accelerating tumor growth.

Contraindicated for Semax: Semax has neurotrophic properties that promote cell growth, which may be concerning in patients with active malignancies.

Contraindicated for MOTS-c: MOTS-c influences cellular metabolism and AMPK pathways. Effects on cancer cell metabolism are not fully understood.

Contraindicated for Tesamorelin: Tesamorelin stimulates growth hormone release, which may promote tumor growth in patients with active malignancies.

Contraindicated for Hexarelin: Hexarelin stimulates growth hormone release, which may promote tumor growth and cell proliferation.

Contraindicated for GHRP-6: GHRP-6 stimulates growth hormone release, which may promote tumor growth in active cancers.

Contraindicated for GHRP-2: GHRP-2 stimulates growth hormone release, which may promote tumor growth in active malignancies.

Contraindicated for Melanotan II: Melanotan II stimulates melanocyte activity. In patients with skin cancers, particularly melanoma, it may accelerate disease progression.

Contraindicated for Dihexa: Dihexa activates hepatocyte growth factor (HGF) pathways, which can promote tumor growth and metastasis.

Contraindicated for Kisspeptin-10: Kisspeptin-10 influences reproductive hormone pathways. Hormone-sensitive cancers may be affected by altered GnRH and gonadotropin levels.

Contraindicated for Humanin: Humanin has anti-apoptotic properties that may protect cancer cells from programmed cell death, potentially supporting tumor survival.

Contraindicated for Retatrutide: Retatrutide acts on multiple metabolic pathways including GLP-1 and GIP receptors. Its effects on cell proliferation in patients with active malignancies have not been fully characterized.

Contraindicated for CJC-1295: CJC-1295 stimulates growth hormone release, which can increase IGF-1 levels. Elevated IGF-1 has been associated with cancer recurrence.

Contraindicated for Ipamorelin: The growth hormone and IGF-1 elevation from Ipamorelin may increase the risk of cancer recurrence.

Contraindicated for Sermorelin: Growth hormone stimulation from Sermorelin elevates IGF-1, which has been linked to increased cancer recurrence risk.

Contraindicated for BPC-157: The pro-angiogenic properties of BPC-157 may potentially support recurrence by promoting blood vessel growth that could feed dormant cancer cells.

Contraindicated for TB-500 (Thymosin Beta-4): The pro-angiogenic and cell-migration properties of TB-500 may increase the risk of cancer recurrence.

Contraindicated for Epithalon (Epitalon): Telomerase activation from Epithalon may increase the risk of cancer recurrence by supporting abnormal cell survival.

Contraindicated for Tesamorelin: Growth hormone and IGF-1 elevation from Tesamorelin may increase risk of cancer recurrence.

Contraindicated for Hexarelin: Elevated growth hormone and IGF-1 from Hexarelin may increase risk of cancer recurrence.

Contraindicated for GHRP-6: Growth hormone and IGF-1 elevation from GHRP-6 may increase risk of cancer recurrence.

Contraindicated for GHRP-2: Elevated IGF-1 from GHRP-2-stimulated growth hormone may increase cancer recurrence risk.

Contraindicated for Melanotan II: Melanocortin stimulation from Melanotan II may increase melanoma recurrence risk in patients with skin cancer history.

Contraindicated for Dihexa: HGF pathway activation from Dihexa may increase cancer recurrence risk through pro-growth signaling.

Contraindicated for Humanin: The cytoprotective effects of Humanin may increase cancer recurrence risk by inhibiting apoptosis in dormant cancer cells.

Contraindicated for Retatrutide: GLP-1 receptor agonists have been linked to thyroid C-cell tumors in animal studies. Retatrutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma.

Contraindicated for Retatrutide: Retatrutide is contraindicated in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) due to the risk of medullary thyroid carcinoma associated with GLP-1 receptor agonists.

Contraindicated for CJC-1295: CJC-1295 has not been studied in pregnancy and may affect fetal development through altered growth hormone levels.

Contraindicated for Ipamorelin: Ipamorelin has not been studied in pregnancy. Altered growth hormone levels may impact fetal development.

Contraindicated for Sermorelin: Sermorelin is not approved for use during pregnancy due to potential effects on fetal growth and development.

Contraindicated for BPC-157: BPC-157 has not been adequately studied in human pregnancy. Its tissue-modulating effects may pose risks to fetal development.

Contraindicated for Thymosin Alpha-1: Immune modulation during pregnancy may disrupt the delicate immune tolerance required for fetal development.

Contraindicated for PT-141: PT-141 is contraindicated in pregnancy as melanocortin receptor activation may affect fetal development.

Contraindicated for AOD-9604: AOD-9604 has not been studied in pregnancy. Its effects on fetal metabolism are unknown.

Contraindicated for TB-500 (Thymosin Beta-4): TB-500 has not been studied in pregnancy. Its tissue-remodeling effects may pose risks to fetal development.

Contraindicated for GHK-Cu: GHK-Cu has not been studied in pregnancy. Copper peptide effects on fetal development are unknown.

Contraindicated for Epithalon (Epitalon): Epithalon has not been studied in pregnancy. Effects on fetal cellular development are unknown.

Contraindicated for Selank: Selank has not been studied in pregnancy. Its neuroactive effects may impact fetal brain development.

Contraindicated for Semax: Semax has not been studied in pregnancy. Its neuroactive and hormonal effects may affect fetal development.

Contraindicated for DSIP (Delta Sleep-Inducing Peptide): DSIP has not been studied in pregnancy. Its neuroendocrine effects may impact fetal development.

Contraindicated for MOTS-c: MOTS-c has not been studied in pregnancy. Its metabolic effects may impact fetal development.

Contraindicated for Tesamorelin: Tesamorelin is contraindicated in pregnancy due to potential effects on fetal growth from altered growth hormone levels.

Contraindicated for Hexarelin: Hexarelin has not been studied in pregnancy. Altered growth hormone levels may impact fetal development.

Contraindicated for GHRP-6: GHRP-6 has not been studied in pregnancy. Growth hormone modulation may affect fetal development.

Contraindicated for GHRP-2: GHRP-2 has not been studied in pregnancy. Its effects on fetal growth and development are unknown.

Contraindicated for Melanotan II: Melanotan II is contraindicated in pregnancy due to unknown effects on fetal development from melanocortin receptor activation.

Contraindicated for LL-37: LL-37 has not been studied in pregnancy. Immune modulation may disrupt maternal-fetal immune tolerance.

Contraindicated for KPV: KPV has not been studied in pregnancy. Its immunomodulatory effects may impact fetal development.

Contraindicated for Dihexa: Dihexa has not been studied in pregnancy. Its neurotrophic and growth factor effects may impact fetal development.

Contraindicated for 5-Amino-1MQ: 5-Amino-1MQ has not been studied in pregnancy. Its metabolic enzyme inhibition may affect fetal development.

Contraindicated for SS-31 (Elamipretide): SS-31 has not been studied in pregnancy. Its effects on mitochondrial function in developing tissues are unknown.

Contraindicated for PE-22-28: PE-22-28 has not been studied in pregnancy. Its neurogenic effects may impact fetal brain development.

Contraindicated for Kisspeptin-10: Kisspeptin-10 directly affects reproductive hormones and GnRH signaling. Use during pregnancy may disrupt hormonal balance critical for fetal development.

Contraindicated for Humanin: Humanin has not been studied in pregnancy. Its effects on fetal cellular development and apoptosis pathways are unknown.

Contraindicated for KLOW: KLOW has not been studied in pregnancy. Effects on fetal development are unknown.

Contraindicated for GLOW: GLOW has not been studied in pregnancy. Effects on fetal development are unknown.

Contraindicated for Retatrutide: Retatrutide has not been studied in pregnancy. GLP-1 receptor agonists may affect fetal development and maternal glucose regulation.

Contraindicated for CJC-1295: Safety of CJC-1295 during breastfeeding has not been established. Growth hormone modulation could affect lactation.

Contraindicated for BPC-157: Insufficient safety data exists for BPC-157 use during breastfeeding.

Contraindicated for PT-141: Safety of PT-141 during breastfeeding has not been established.

Contraindicated for AOD-9604: Insufficient safety data for AOD-9604 during breastfeeding.

Contraindicated for Selank: Safety of Selank during breastfeeding has not been established. Neuroactive peptides may pass into breast milk.

Contraindicated for DSIP (Delta Sleep-Inducing Peptide): Safety of DSIP during breastfeeding has not been established.

Contraindicated for KPV: Safety of KPV during breastfeeding has not been established.

Contraindicated for 5-Amino-1MQ: Safety of 5-Amino-1MQ during breastfeeding has not been established.

Contraindicated for PE-22-28: Safety of PE-22-28 during breastfeeding has not been established. Neuroactive peptides may pass into breast milk.

Contraindicated for Kisspeptin-10: Kisspeptin-10 modulates reproductive hormones, which may affect lactation and hormonal balance during breastfeeding.

Contraindicated for KLOW: Safety of KLOW during breastfeeding has not been established.

Contraindicated for GLOW: Safety of GLOW during breastfeeding has not been established.

Contraindicated for Retatrutide: Safety of Retatrutide during breastfeeding has not been established. It is unknown whether the peptide is excreted in breast milk.

Contraindicated for CJC-1295: Growth hormone elevation from CJC-1295 can worsen diabetic retinopathy by promoting abnormal blood vessel growth in the retina.

Contraindicated for Ipamorelin: Elevated growth hormone from Ipamorelin can accelerate retinal neovascularization in diabetic retinopathy.

Contraindicated for GHRP-6: Elevated growth hormone from GHRP-6 can worsen diabetic retinopathy by promoting abnormal blood vessel growth.

Contraindicated for GHRP-2: Growth hormone elevation from GHRP-2 can accelerate retinal neovascularization in diabetic retinopathy.

Contraindicated for Retatrutide: Rapid improvement in glycemic control from Retatrutide may temporarily worsen diabetic retinopathy. Close ophthalmologic monitoring is recommended.

Contraindicated for CJC-1295: Growth hormone-releasing peptides can elevate intracranial pressure, worsening existing intracranial hypertension.

Contraindicated for Sermorelin: Growth hormone elevation from Sermorelin can increase intracranial pressure.

Contraindicated for Tesamorelin: Growth hormone elevation from Tesamorelin can increase intracranial pressure.

Contraindicated for CJC-1295: CJC-1295 acts on the pituitary gland. Existing pituitary disorders may lead to unpredictable or dangerous hormone responses.

Contraindicated for Ipamorelin: Ipamorelin directly stimulates the pituitary gland. Pre-existing pituitary conditions may result in adverse hormonal responses.

Contraindicated for Sermorelin: Sermorelin requires a functioning pituitary gland. Pituitary disorders may prevent proper response or cause adverse effects.

Contraindicated for DSIP (Delta Sleep-Inducing Peptide): DSIP affects neuroendocrine signaling involving the pituitary gland. Pre-existing pituitary conditions may lead to unpredictable effects.

Contraindicated for Tesamorelin: Tesamorelin acts directly on the pituitary gland. Pre-existing pituitary disorders may cause unpredictable hormonal responses.

Contraindicated for Hexarelin: Hexarelin acts on the pituitary gland. Pre-existing pituitary conditions may result in adverse hormonal responses.

Contraindicated for GHRP-6: GHRP-6 acts directly on the pituitary gland. Pre-existing disorders may cause adverse hormonal effects.

Contraindicated for GHRP-2: GHRP-2 directly stimulates the pituitary gland. Pre-existing pituitary disorders may cause unpredictable responses.

Contraindicated for Kisspeptin-10: Kisspeptin-10 stimulates the hypothalamic-pituitary axis. Pre-existing pituitary disorders may lead to unpredictable hormonal responses.

Contraindicated for Thymosin Alpha-1: Thymosin Alpha-1 stimulates T-cell activity and immune response. In patients with autoimmune conditions, this can trigger disease flares.

Contraindicated for Epithalon (Epitalon): Epithalon may modulate immune function through its effects on the pineal gland, potentially exacerbating autoimmune conditions.

Contraindicated for Melanotan II: Melanotan II modulates immune function through melanocortin receptors, potentially exacerbating autoimmune conditions.

Contraindicated for LL-37: LL-37 is a potent immune activator. In autoimmune conditions, it may trigger inflammatory flares and worsen disease activity.

Contraindicated for KLOW: Peptide blends may modulate immune function. Patients with autoimmune conditions should consult their provider before use.

Contraindicated for GLOW: Peptide blends may modulate immune function. Patients with autoimmune conditions should consult their provider before use.

Contraindicated for Thymosin Alpha-1: Thymosin Alpha-1 enhances immune function, which directly counteracts immunosuppressive therapy required to prevent organ rejection.

Contraindicated for LL-37: LL-37 enhances immune function, which may counteract immunosuppressive therapy in transplant recipients.

Contraindicated for PT-141: PT-141 affects blood pressure and cardiovascular function. Patients with heart disease face increased risk of adverse cardiac events.

Contraindicated for Hexarelin: Hexarelin has been shown to affect cardiac function and cortisol release. Patients with cardiovascular disease should use caution.

Contraindicated for Melanotan II: Melanotan II affects cardiovascular function and can cause nausea and flushing. Heart disease patients should avoid use.

Contraindicated for PT-141: PT-141 can cause transient increases in blood pressure. Uncontrolled hypertension increases the risk of cardiovascular events.

Contraindicated for Semax: Semax can influence blood pressure regulation. Patients with uncontrolled hypertension should use caution.

Contraindicated for Melanotan II: Melanotan II can cause blood pressure fluctuations. Patients with uncontrolled hypertension face increased cardiovascular risk.

Contraindicated for Dihexa: Dihexa may influence cardiovascular function. Patients with uncontrolled hypertension should exercise caution.

Contraindicated for AOD-9604: Patients with severe kidney disease may have impaired clearance of AOD-9604 metabolites.

Contraindicated for MOTS-c: Patients with severe kidney disease may have impaired clearance of MOTS-c metabolites.

Contraindicated for 5-Amino-1MQ: Patients with kidney disease may have impaired clearance of 5-Amino-1MQ metabolites.

Contraindicated for SS-31 (Elamipretide): Patients with severe kidney disease may have impaired clearance of SS-31 and its metabolites.

Contraindicated for Retatrutide: Patients with severe kidney disease may have impaired clearance of Retatrutide. Dose adjustment or avoidance may be necessary.

Contraindicated for GHK-Cu: Copper metabolism is heavily dependent on liver function. Patients with liver disease may accumulate copper to toxic levels.

Contraindicated for 5-Amino-1MQ: 5-Amino-1MQ affects metabolic enzyme pathways. Patients with liver disease may experience altered drug metabolism and increased toxicity risk.

Contraindicated for Retatrutide: Retatrutide is metabolized hepatically. Patients with significant liver impairment may experience altered drug levels and increased risk of adverse effects.

Contraindicated for Retatrutide: GLP-1 receptor agonists, including Retatrutide, have been associated with an increased risk of pancreatitis. Patients with a history of pancreatitis should avoid use.

Contraindicated for BPC-157: BPC-157 affects the nitric oxide system and may influence blood clotting. Patients with clotting disorders should avoid use.

Contraindicated for TB-500 (Thymosin Beta-4): TB-500 can influence blood clotting pathways. Patients with clotting disorders or on anticoagulants should avoid use.

Contraindicated for Selank: Selank is derived from tuftsin, which can influence immune and coagulation pathways. Patients with clotting disorders should use caution.

Contraindicated for SS-31 (Elamipretide): SS-31 has been associated with injection site reactions. Patients with known peptide allergies should be monitored.

Contraindicated for KLOW: Multi-component peptide blends carry increased risk of allergic reactions. Patients with known peptide allergies should be monitored.

Contraindicated for GLOW: Multi-component peptide blends carry increased risk of allergic reactions. Patients with known peptide allergies should be monitored.

Contraindicated for Thymosin Alpha-1: Thymosin Alpha-1 directly opposes immunosuppressive medications, potentially causing dangerous drug interactions.

Contraindicated for LL-37: LL-37 stimulates immune responses, potentially opposing immunosuppressive medications.

Contraindicated for KPV: KPV has anti-inflammatory and immune-modulating effects that may interact with immunosuppressive medications.

Current Medications

List all medications, supplements, and treatments you are currently using.

Additional Notes

Medical Disclaimer

This screening questionnaire is for informational and pre-consultation purposes only. It does not constitute medical advice, diagnosis, or a treatment recommendation.

All peptide therapy protocols must be prescribed and supervised by a licensed healthcare provider. The contraindication information provided here is based on general clinical guidelines and may not reflect every individual’s unique medical circumstances.

Peptide therapies are used off-label in many cases. Results vary by individual. Borderfreehealth.com does not guarantee outcomes from any peptide therapy program.

By submitting this form, you acknowledge that a qualified medical professional will review your responses and determine appropriate treatment options. Do not discontinue any current medications or begin any new treatment based solely on the results of this screening.